|
Feb 9
|
Ionis' (IONS) Eplontersen Gets Fast Track Tag for New Indication
|
|
Feb 9
|
Foghorn (FHTX) Jumps 55% as Lilly Takes Up FHD-909 Development
|
|
Feb 9
|
Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?
|
|
Feb 9
|
ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock?
|
|
Feb 7
|
Deciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beat
|
|
Feb 7
|
Immunogen Inc SVP & CHIEF BUSINESS OFFICER Stacy Coen Sells 4,583 Shares
|
|
Feb 3
|
AbbVie Inc. (NYSE:ABBV) Q4 2023 Earnings Call Transcript
|
|
Feb 3
|
Q4 2023 Abbvie Inc Earnings Call
|
|
Feb 2
|
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
|
|
Jan 9
|
How ImmunoGen (IMGN) Stock Stands Out in a Strong Industry
|
|
Jan 1
|
Is Arvinas (ARVN) Outperforming Other Medical Stocks This Year?
|
|
Dec 26
|
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
|
|
Dec 22
|
Are Investors Undervaluing ImmunoGen, Inc. (NASDAQ:IMGN) By 38%?
|
|
Dec 10
|
ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASH
|
|
Dec 10
|
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
|
|
Dec 8
|
Biotech Deals Are Heating Up. Why 2024 Could Be Even Hotter for M&A.
|
|
Dec 8
|
$19 Billion in a Week: AbbVie Makes Two Big Bets
|
|
Dec 7
|
Why Is Esperion Therapeutics (ESPR) Up 51.4% Since Last Earnings Report?
|
|
Dec 7
|
AbbVie acquiring Cerevel Therapeutics in $8.7B deal
|
|
Dec 7
|
AbbVie to focus on smaller deals after buying spree
|